Video Trends in Pharma Packaging, Administration & Drug Delivery Devices Faster, more cost-efficient hospital-based injectable drug delivery - How speed and convenience imperatives in the Covid-19 crisis have challenged the paradigms Overview and a discussion on the evolution of next-generation products Moderator: Yasemin Karanis, Consultant, European Thought Leadership, IQVIA Global Pharma: Trends in Drug Delivery and Formulations -Yasemin Karanis, Consultant, European Thought Leadership, IQVIA The increasing importance of connected devices and digitalization in post-pandemic R&D - Sai Shankar, Vice President, Global Digital Healthcare Systems, Aptar Pharma Illustration of implementing user experience key aspects and outlining holistic integrated combination products support - Mark Tunkel, Director of Business Development, Insight Innovation Center, Nemera Faster, more cost-efficient hospital-based injectable drug delivery - How speed and convenience imperatives in the Covid-19 crisis have challenged the paradigms - Sagar Bejalwar, Global Acute and Specialty Portfolio Leader, BD Medical Pharmaceutical Systems Trends in sustainable packaging in the FMCG market - how this influences the Pharma business and ongoing developments - Armin Ullmann, Product Manager Sustainable Healthcare Laminates, Huhtamaki Flexible Packaging Sustainable packaging in Merck supply chain ongoing and future developments - Corinne Ondo, Head of Sourcing Glass & Healthcare Innovation Group Procurement, Merck Healthcare This presentation was originally aired as part of the CPHI Festival of Pharma
Why Some Retatrutide Timelines Look Faster Online Online reports can make retatrutide sound faster than the clinical literature because early appetite suppression is easier to notice than endpoint-level body-weight change
Analyzing the current situation regarding GLP-1 receptor agonists, the formulations that are approved are as follows: For Liraglutide: Injectable form for Type-2 Diabetes treatment Injectable form for weight loss and obesity For Semaglutide: Injectable form for Type-2 Diabetes treatment Injectable form for weight loss and obesity Oral tablets for Type-2 Diabetes treatment In both Liraglutide and Semaglutide, there is a need for more supplies, as with all medications containing these active ingredients, a global supply shortage exists
Am J Physiol Renal Physiol (2013) 304:F13744
